Is mazdutide available outside of China?

Name: Mazdutide
Price: 439 USD
Availability: InStock

Mazdutide is primarily in clinical development in China by Innovent Biologics. Research-grade material is available internationally, but the compound has not received regulatory approval in Western markets. Phase 3 trials are ongoing in China.

New

Mazdutide

Once-weekly dual GLP-1 and glucagon receptor agonist developed by Innovent Biologics. Phase 2 data in a Chinese population showed up to 11.3% weight reduction

Fat LossGH Boost

● In Stock

Select Variant

Quantity (vials)

Buy more, save more

—

1+ vials

−5%

3+ vials

−10%

5+ vials

−20%

10+ vials

Total Price

$440

For research & laboratory use only. Not for human consumption.

Half-Life

5-7 days

Administration Route

Subcutaneous injection

GLP-1 / Glucagon Dual

Dual agonism drives both appetite suppression & fat oxidation

Emerging Efficacy Data

Phase 2 showing competitive weight loss vs tirzepatide

NASH Potential

Hepatic glucagon activation reduces liver fat

Effect Profile

Based on primary research mechanisms

Fat Loss

Hunger Control

Metabolic Health

Energy

Mechanism of Action

Mazdutide co-activates GLP-1 and glucagon receptors with a lipidation strategy enabling once-weekly dosing. GLP-1 receptor activation reduces appetite and promotes insulin secretion. Glucagon receptor activation increases hepatic fatty acid oxidation and resting energy expenditure. The dual mechanism is mechanistically similar to survodutide but represents an independently developed molecular scaffold optimised for the co-agonist profile.